Annelies Posen

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

S. Vermeire, E. Louis, M. Ferrante, 2020, Alimentary pharmacology & therapeutics.

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.

E. Van Cutsem, M. Ferrante, F. Baert, 2023, European journal of cancer.

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

D. Franchimont, S. Vermeire, M. Ferrante, 2018, Journal of Crohn's & colitis.

Su1846 – Outcomes of Pregnancy in IBD Patietns Treated with Vedolizumab, Anti-TNF Or Conventional Therapy

S. Vermeire, E. Louis, M. Ferrante, 2019, Gastroenterology.

DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy

S. Vermeire, M. Ferrante, A. Shitrit, 2019, Journal of Crohn's and Colitis.

Sa1697 - Outcome of Pregnancies in Vedolizumab Treated Female IBD Patients

D. Franchimont, S. Vermeire, M. Ferrante, 2018 .

OP032 Outcome of pregnancies in female IBD patients treated with vedolizumab

D. Franchimont, S. Vermeire, M. Ferrante, 2018 .